{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:13:17Z","timestamp":1648559597570},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,8,25]],"date-time":"2007-08-25T00:00:00Z","timestamp":1188000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00393-007-0194-0","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T05:11:36Z","timestamp":1187845896000},"page":"441-443","source":"Crossref","is-referenced-by-count":1,"title":["Mycophenolat Mofetil als Remissionsinduktion bei M.\u00a0Wegener"],"prefix":"10.1007","volume":"66","author":[{"given":"I.","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,25]]},"reference":[{"key":"194_CR1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"Groot","year":"2005","unstructured":"Groot K de, Rasmussen N, Bacon PA et al. (2005) Randomised trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vascultits. Arthritis Rheum 52: 2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"194_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02813430510015269","volume":"34","author":"Omdal","year":"2005","unstructured":"Omdal R, Wildhagen K, Hansen T et al. (2005) Anti-CD20 therapy of tretment-resistant Wegener\u2019s granulomatosis: favorable but temporary response. Scand J Rheumatol 34: 229\u2013232","journal-title":"Scand J Rheumatol"},{"key":"194_CR3","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","volume":"54","author":"Smith","year":"2006","unstructured":"Smith KG, Jones RB, Burns SM, Jayne DR (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 54: 2970\u20132982","journal-title":"Arthritis Rheum"},{"key":"194_CR4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","volume":"14","author":"Birck","year":"2003","unstructured":"Birck R, Warnatz K, Lorenz HM et al. (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14: 440\u2013447","journal-title":"J Am Soc Nephrol"},{"key":"194_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10067-004-1002-8","volume":"24","author":"Benenson","year":"2005","unstructured":"Benenson E, Fries JW, Heilig B et al. (2005) High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener\u2019s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide. Clin Rheumatol 24: 251\u2013257","journal-title":"Clin Rheumatol"},{"key":"194_CR6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D et al. (2000) Intravenous immunoglobulin for ANCA associated systemic vasculitis with persistent disease activity. QJM 93: 433\u2013439","journal-title":"QJM"},{"key":"194_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/keh009","volume":"43","author":"Metzler","year":"2004","unstructured":"Metzler C, Fink C, Lamprecht P et al. (2004) Maintenance of remisison with leflunomide in Wegener\u2019s granulomatosis. Rheumatology 43: 315\u2013320","journal-title":"Rheumatology"},{"key":"194_CR8","doi-asserted-by":"crossref","unstructured":"Henes JC, Fritz J, Koch S et al. (2007) Rituximab for treatment-resistant extensive Wegener\u2019s granulomatosis \u2013 additive effects of a maintenance treatment with leflunomide. Clin Rheumatol [Epub ahead of print, May 15]","DOI":"10.1007\/s10067-007-0643-9"},{"key":"194_CR9","first-page":"80","volume":"30","author":"Koldingsness","year":"2003","unstructured":"Koldingsness W, Nossent JC (2003) Baseline features and initial treatment as predictors of remisison or relapse in Wegener\u2019s granulomatosis. J Rheumatol 30: 80\u201388","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0194-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0194-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0194-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:39Z","timestamp":1559046579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0194-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,25]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0194-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,25]]}}}